Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

This Chip Stock Could Yield Substantial Returns, but Is It Worth the Risk?
This Chip Stock Could Yield Substantial Returns, but Is It Worth the Risk?

In today's video, I discuss Wolfspeed (NYSE: WOLF), its business strategy, growth opportunities, potential risks, and why artificial intelligence stock investors should not ignore this massive

Can Axon Double Again This Year?
Can Axon Double Again This Year?

Among last year's top gainers was Axon Enterprise (NASDAQ: AXON), which makes tech-based software and hardware for the law enforcement and public safety industries.

Axon has been a winning stock for

Is Etsy Stock Still a Leader in E-Commerce?
Is Etsy Stock Still a Leader in E-Commerce?

Explore the exciting world of Etsy (NASDAQ: ETSY) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and

Should You Buy Intuitive Machines While It's Below $22?
Should You Buy Intuitive Machines While It's Below $22?

Space exploration has evolved dramatically since the first satellites were launched in the late 1950s.

Once dominated by governments, it has shifted to the private sector, with companies like SpaceX

Power Integrations’ Latest MotorXpert Software Drives FOC Motors Without Shunts or Sensors
Power Integrations’ Latest MotorXpert Software Drives FOC Motors Without Shunts or Sensors


Power Integrations (NASDAQ: POWI), the leader in high-voltage integrated circuits for energy-efficient power conversion, today announced MotorXpert™ v3.0, a software suite for configuration

EQS-Adhoc: VARTA AG: Regional Court Stuttgart rejects appeals against the restructuring court’s plan confirmation decision as inadmissible, VARTA AG’s restructuring plan hence legally binding: https://upload.wikimedia.org/wikipedia/commons/thumb/1/13/Varta-Logo.svg/1000px-Varta-Logo.svg.png
EQS-Adhoc: VARTA AG: Regional Court Stuttgart rejects appeals against the restructuring court’s plan confirmation decision as inadmissible, VARTA AG’s restructuring plan hence legally binding
EQS-Adhoc: VARTA AG: Regional Court Stuttgart rejects appeals against the restructuring court’s plan confirmation decision as inadmissible, VARTA AG’s restructuring plan hence legally binding
EQS-Adhoc: VARTA AG: Regional Court Stuttgart rejects appeals against the restructuring court’s plan confirmation decision as inadmissible, VARTA AG’s restructuring plan hence legally binding: https://upload.wikimedia.org/wikipedia/commons/thumb/1/13/Varta-Logo.svg/1000px-Varta-Logo.svg.png
EQS-Adhoc: VARTA AG: Regional Court Stuttgart rejects appeals against the restructuring court’s plan confirmation decision as inadmissible, VARTA AG’s restructuring plan hence legally binding
EQS-Adhoc: VARTA AG: Regional Court Stuttgart rejects appeals against the restructuring court’s plan confirmation decision as inadmissible, VARTA AG’s restructuring plan hence legally binding
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
EQS-News: FUCHS further expands its footprint in South America with a Joint Venture in Peru
EQS-News: FUCHS further expands its footprint in South America with a Joint Venture in Peru
EQS-News: FUCHS further expands its footprint in South America with a Joint Venture in Peru
EQS-News: Nagarro expects revenues of between €1,020 and €1,080 million for 2025: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-News: Nagarro expects revenues of between €1,020 and €1,080 million for 2025
EQS-News: Nagarro expects revenues of between €1,020 and €1,080 million for 2025
EQS-News: Nagarro expects revenues of between €1,020 and €1,080 million for 2025: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-News: Nagarro expects revenues of between €1,020 and €1,080 million for 2025
EQS-News: Nagarro expects revenues of between €1,020 and €1,080 million for 2025
EQS-Adhoc: Nagarro SE ended talks regarding a potential take-private to pursue alternative strategic option: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-Adhoc: Nagarro SE ended talks regarding a potential take-private to pursue alternative strategic option
EQS-Adhoc: Nagarro SE ended talks regarding a potential take-private to pursue alternative strategic option
EQS-Adhoc: Nagarro SE ended talks regarding a potential take-private to pursue alternative strategic option: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-Adhoc: Nagarro SE ended talks regarding a potential take-private to pursue alternative strategic option
EQS-Adhoc: Nagarro SE ended talks regarding a potential take-private to pursue alternative strategic option
Semtech Achieves 5G RedCap Certification with AT&T
Semtech Achieves 5G RedCap Certification with AT&T


Semtech Corporation (Nasdaq: SMTC), a high-performance semiconductor, Internet of Things (IoT) systems and cloud connectivity service provider, today announced a key milestone in 5G RedCap (reduced

Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
If You'd Invested $10,000 in Axon Enterprise Stock 24 Years Ago at its IPO, Here's How Much You'd Have Today
If You'd Invested $10,000 in Axon Enterprise Stock 24 Years Ago at its IPO, Here's How Much You'd Have Today

Axon Enterprise (NASDAQ: AXON) has been one of the most successful under-the-radar stock market investments of this century. The company, best known for its Taser line of stun guns and other law

EQS-News: Evotec receives grant from Korean Government to develop novel antibody-based treatments for lung diseases
EQS-News: Evotec receives grant from Korean Government to develop novel antibody-based treatments for lung diseases
EQS-News: Evotec receives grant from Korean Government to develop novel antibody-based treatments for lung diseases
Where Will Moderna Be in 3 Years?
Where Will Moderna Be in 3 Years?

As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural for investors to wonder about where the biotech will go in the near

Semtech's HL7900 5G LPWA Module Certified by Leading U.S. Carriers
Semtech's HL7900 5G LPWA Module Certified by Leading U.S. Carriers


Semtech Corporation (Nasdaq: SMTC), a high-performance semiconductor, Internet of Things (IoT) systems, and cloud connectivity service provider, today announced the certification of the HL7900

EQS-News: Commerzbank completes share buyback of €600 m – Second tranche of up to €400 m applied for
EQS-News: Commerzbank completes share buyback of €600 m – Second tranche of up to €400 m applied for
EQS-News: Commerzbank completes share buyback of €600 m – Second tranche of up to €400 m applied for
EQS-Adhoc: Nemetschek SE: Preliminary results for the financial year 2024 - Revenue growth exceeds outlook, profitability slightly above forecasted range
EQS-Adhoc: Nemetschek SE: Preliminary results for the financial year 2024 - Revenue growth exceeds outlook, profitability slightly above forecasted range
EQS-Adhoc: Nemetschek SE: Preliminary results for the financial year 2024 - Revenue growth exceeds outlook, profitability slightly above forecasted range
EQS-Adhoc: Nemetschek SE: Preliminary results for the financial year 2024 - Revenue growth exceeds outlook, profitability slightly above forecasted range
EQS-Adhoc: Nemetschek SE: Preliminary results for the financial year 2024 - Revenue growth exceeds outlook, profitability slightly above forecasted range
EQS-Adhoc: Nemetschek SE: Preliminary results for the financial year 2024 - Revenue growth exceeds outlook, profitability slightly above forecasted range
EQS-Adhoc: LANXESS Aktiengesellschaft: EBITDA pre exceptionals for the fourth quarter significantly above market expectation
EQS-Adhoc: LANXESS Aktiengesellschaft: EBITDA pre exceptionals for the fourth quarter significantly above market expectation
EQS-Adhoc: LANXESS Aktiengesellschaft: EBITDA pre exceptionals for the fourth quarter significantly above market expectation
EQS-News: Growth financing: SIXT successfully places EUR 500 million bond at top conditions
EQS-News: Growth financing: SIXT successfully places EUR 500 million bond at top conditions
EQS-News: Growth financing: SIXT successfully places EUR 500 million bond at top conditions
A Once-in-a-Decade Opportunity: 1 Magnificent Dividend Stock Down 36% to Buy Hand Over Fist in 2025
A Once-in-a-Decade Opportunity: 1 Magnificent Dividend Stock Down 36% to Buy Hand Over Fist in 2025

After briefly trading for more than $400 in 2024, shares of buffalo wing franchisor Wingstop (NASDAQ: WING) have plummeted 36%. Despite this decline, the growth stock still trades at a lofty